Skip to Main Content

INFORMATION FOR

Appointments & Promotions Committees

The process of receiving an appointment or a promotion at the Yale School of Medicine is lengthy, and each department maintains information about its own process, requirements and timetable. However, there are certain school-wide requirements that apply to everyone.

All appointments and promotions must be approved by one of two Appointments and Promotions Committees, which are composed of the dean or deputy dean of the Yale School of Medicine and senior faculty who represent a wide range of ladder faculty in relationship to department, academic, track, and areas of expertise. The Committees meet from February to June to discuss and vote on faculty proposals submitted by the departments.

Current appointment and promotions committee memberships are listed below:

Senior Appointments & Promotions Committee

  • Committee Chair

    Jean and David W. Wallace Dean of the Yale School of Medicine and C.N.H. Long Professor of Internal Medicine

    Dr. Brown graduated from Yale College, where she majored in molecular biophysics and biochemistry. She earned her medical degree from Harvard University. She completed internship and residency programs in medicine at Vanderbilt University, where she also did a fellowship in clinical pharmacology. Dr. Brown joined the faculty of Vanderbilt in 1992 and held a number of leadership positions, serving as chief of the Division of Clinical Pharmacology, associate dean for clinical and translational scientist development, and Robert H. Williams professor before becoming the Hugh J. Morgan Chair of Medicine and physician-in-chief of Vanderbilt University Hospital in 2010. In 2020, she became Jean and David W. Wallace Dean of Medicine and C.N.H. Long Professor of Internal Medicine at Yale School of Medicine. Dr. Brown has long been committed to medical education and mentorship. At Vanderbilt, she established the Elliot Newman Society to support the development of physician-scientists and co-founded the Vanderbilt Master of Science in Clinical Investigation program. Her research has defined the molecular mechanisms through which commonly prescribed blood pressure and diabetes drugs affect the risk of cardiovascular and kidney disease. In her clinical practice, she has treated patients with resistant and secondary forms of hypertension. Dr. Brown has served as a member of the NIH National Advisory Research Resources Council and the National Heart, Lung, and Blood Advisory Council. She was president of the Association of Professors of Medicine. In 2019, she was elected a Master of the American College of Physicians.Her numerous awards include election to the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.   She is a member of the American Association of Arts and Sciences.
  • Committee Co-Chair

    Harold W. Jockers Professor of Medicine, Deputy Dean for Academic Affairs

    Dr. Linda Bockenstedt is the Harold W. Jockers Professor of Medicine, Section of Rheumatology, and Deputy Dean for Faculty Affairs at Yale School of Medicine. She received her undergraduate degree in chemistry and physics from Harvard College and is a graduate of the Ohio State University School of Medicine. After completing residency training in medicine and serving as Chief Resident in Medicine at Yale, Dr. Bockenstedt obtained rheumatology clinical and research fellowship training at the University of California, San Francisco. She has been a faculty member at Yale School of Medicine since 1989, where she directs a research program devoted toward understanding the pathogenesis of Lyme disease, an infection-related rheumatic disease. Her research has been continually supported by the National Institutes of Health since 1990, and she is internationally recognized for her studies of the host immune response to spirochetal infection. She is also an active clinician and educator for medical trainees.Dr. Bockenstedt is an elected member of the Kunkel Society and the Interurban Clinical Club. She is a former standing member of the Immunity and Host Defense Study Section at NIH and former member of the Board of Directors for the American College of Rheumatology Research & Education Foundation. Since 2006 she has been active in faculty affairs at Yale School of Medicine, first as Director for Professional Development & Equity, then as an Associate Dean for Faculty Affairs at Yale School of Medicine,
  • Term 2020-2023

    Professor, Obstetrics, Gynecology & Reproductive Sciences; Director, Division of Reproductive Sciences, Department of Obstetrics, Gynecology & Reproductive Sciences

    Dr Vikki Abrahams is a Professor and Director of the Division of Reproductive Sciences in the Department of Obstetrics, Gynecology and Reproductive Sciences.Dr Abrahams received her B.Sc. (hons) in Immunology in 1996, and was awarded a Ph.D. in Immunology in 2000, both from University College London. She continued her studies as a postdoctoral associate at Dartmouth Medical School and then at Yale University in the field of Reproductive Immunology. In 2004 she joined the faculty in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. Since 2006 she has also been an Honorary Lecturer in the Maternal and Fetal Health Research Center at The University of Manchester, UK. Dr Abrahams' research focuses on understanding the role of innate immune Toll-like receptor and Nod-like receptor family members in placental and maternal-fetal immune responses, and their role in regulating pregnancy outcome, including those complicated by infections and by autoimmune diseases. Studies from the Abrahams laboratory has characterized the mechanisms by which Toll-like receptors, Nod-like receptors, and the inflammasome function in the placental trophoblast and fetal membranes in response to both infectious and non-infectious stimuli.Dr Abrahams is a member of the American Association of Immunologists, International Society for Immunology of Reproduction, Society for Reproductive Investigation, and the American Society of Reproductive Immunology. Dr Abrahams is the Associate Editor for Reviews of the American Journal of Reproductive Immunology and also serves on the editorial boards for a number of other journals within the Reproductive Sciences field.
  • Term 2020-2023

    John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, and in the Child Study Center and of Radiology and Biomedical Imaging; Director, Mood Disorders Research Program

    Dr. Hilary Patricia Blumberg is the John and Hope Furth Professor of Psychiatric Neuroscience, Professor of Psychiatry, Radiology and Biomedical Imaging and in the Child Center, and Director of the Mood Disorders Research Program, at the Yale School of Medicine. She graduated summa cum laude in neuroscience from Harvard University and completed her medical degree, psychiatry training and specialty training in brain scanning research at Cornell University Medical College. Dr. Blumberg’s research is devoted to understanding the brain circuitry differences that underlie mood disorders across the lifespan, with a focus on bipolar disorder and on suicide prevention. She directs the Mood Disorders Research Program at Yale that brings together a multi-disciplinary group of scientists to study the genetic, developmental and environmental factors that cause mood disorders to develop new methods for early detection, more effective interventions, and prevention of the disorders and their associated high risk for suicide. This research includes the use of new state-of-the-art brain scanning methods. The program is also known for training young scientists to be new leaders in the field. Dr. Blumberg has served as principal investigator on awards from the National Institute of Mental Health, National Institute on Drug Abuse, Department of Veterans Affairs, American Foundation for Suicide Prevention, Brain and Behavior Research Foundation, International Bipolar Disorder Foundation, For the Love of Travis Foundation, MQ Foundation, Stanley Medical Research Institute and Women’s Health Research at Yale. She has received numerous awards including the 2021 International Society of Bipolar Disorders Mogens Schou Award for Research in Bipolar Disorder, 2021 Sethi Award, 2018 American Psychiatric Association Blanche F. Ittleson Award for outstanding and published research in child and adolescent psychiatry and 2017 Brain and Behavior Foundation Colvin Prize for Research Achievement in Mood Disorders. In 2021, she was nominated for the Leonard Tow Humanism in Medicine Award. She is a fellow of the American Psychiatric Association and of the American College of Neuropsychopharmacology and a member of the Society of Biological Psychiatry.
  • Term 2020-2023

    Professor of Surgery (Thoracic); Division Chief, Thoracic Surgery; Clinical Director, Center for Thoracic Cancers

    Daniel J. Boffa, MD, is a Professor of Thoracic Surgery at Yale School of Medicine. He earned his medical degree from the University of Chicago Pritzker School of Medicine and is a Board Certified Surgeon and a Board Certified Thoracic Surgeon. His international work includes traveling to Leuven, Belgium, for a presentation for the European Society of Thoracic Surgeons and the ASN/ISN World Congress of Nephrology. He has written many papers and publications in his field and has received numerous awards and recognitions, including the Dr. Charles H. Bryan Clinical Excellence Award, Thoracic and Cardiovascular Research Award, and the American Association of Thoracic Surgery Resident Traveling Fellowship.Learn more about Dr. Boffa>>Dr. Boffa specializes in esophageal and lung cancer, achalasia, gastroesophageal reflux disease, hiatal hernia, esophageal diverticulum, and hyperhidrosis. As a highly skilled surgeon, Dr. Boffa performs the majority of his surgeries with minimally invasive procedures. Committed to increasing the survival rate of cancer patients, Dr. Boffa has focused his clinical research on the prevention of tumor metastasis and the early detection of lung cancer.Learn more about one of Yale Thoracic Surgery's surgeons.
  • Term 2022-2025

    Rothberg Professor of Neurosurgery; Co Vice Chair of Research, Neurosurgery

    Dr. Angélique Bordey holds the rank of Professor of Neurosurgery, and Cellular & Molecular Physiology. Dr. Bordey is an active participant in teaching and training of graduate and medical students at Yale School of Medicine. Dr. Bordey is an  Editor for several journals and on the advisory board of CURE epilepsy and the TSC Alliance preclinical consortium. She has served as a permanent member on several grant review committees and NIH study sections. Finally, she is a McKnight awardee and holds several federal and foundation grants as well as patents for the treatment of epilepsy.
  • Term 2022-2025

    Professor of Psychiatry; Medical Director Hispanic Clinic and Latino Behavioral Health System; Associate Director Psychiatry Residency Program

    Esperanza Díaz M.D. attended Javeriana University in Bogotá, Colombia, and completed Psychiatry residency training at Yale. She graduated from the Western New England Institute for Psychoanalysis. As medical director of the Hispanic Clinic and its expansion to the community, mental health services for Limited English proficiency populations are a model. She founded the Hispanic Psychiatry Fellowship addressing mental health disparities in Latinos. Along with residents, she developed the Cultural Psychiatry curriculum, a predecessor of the Social Justice and Health Equity curriculum. Her work with the medical school Teaching and Learning Center addresses cultural sensitivity and microaggressions management training. Using an experiential model, she leads interviewing training for residents. She chairs the evaluation committee to review and revise the Yale Psychiatry evaluation system.
  • Term 2022-2025

    Professor of Internal Medicine (Endocrinology) and Neuroscience

    Elizabeth Jonas received training in Neurology and Internal Medicine. She developed an interest in Neuroscience while studying as a medical student with Dr. Rodolfo Llinas at N.Y.U. and at the Marine Biological Laboratory. With Dr. Llinas she developed an interest in calcium control of synaptic transmission. She pursued this interest as a post-doctoral fellow in the laboratory of Dr. Leonard Kaczmarek, Yale Pharmacology. Dr. Jonas developed a technique for recording from ion channels on intracellular membranes and has used this and other techniques to study mitochondria. Mitochondria are necessary for life and death of neurons and other cells. Regulation of mitochondrial metabolism is also key to energy efficiency in the nervous system. Dr. Jonas is now studying the role of mitochondria and energy efficiency in neurodegenerative disease states and in learning and memory formation in healthy brain. Her lab has recently characterized the molecular identity of the cell death channel known as the mitochondrial permeability transition pore and is now studying how inhibiting gating of the pore may ameliorate stroke, neurodegenerative and developmental brain diseases.
  • Term 2020-2023

    Professor of Medicine (Cardiology); Director, Cardiology; Director of Yale UCLP Clinical Research Program Yale University School of Medicine, New Haven, CT, The Barts Heart Center and Queen Mary University of London, Cardiology

    Alexandra J. Lansky, MD, is Professor of Medicine in the section of Cardiology at the Yale School of Medicine and a practicing cardiologist at Yale-New Haven Hospital, in New Haven, CT. Dr. Lansky joined Yale in 2010 as Director of the Yale Heart and Vascular Clinical Research Program and the Cardiovascular Research Center (YCRC), which specializes in the conduct of national and international cardiovascular clinical trials with specific expertise in the evaluation of interventional devices. She most recently received a dual appointment as Chair of Cardiovascular Research at Queen Mary University in London as part of the Yale and London based Barts Heart Center transatlantic research collaboration. From 2004 to 2010 Dr. Lansky was Associate Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Clinical Services at the Center for Interventional Vascular Therapy, a practicing cardiologist at New York-Presbyterian, and Chief Scientific Officer of the Cardiovascular Research Foundation Clinical Trials Center.Prior to that she was an interventional cardiologist on faculty at Washington Hospital Center in Washington, DC, and at Lenox Hill Hospital in New York, NY. She has dedicated her career to leading clinical and angiographic evaluations of more than 500 clinical trials in a broad range of ischemic cardiovascular therapeutic areas, including pharmacologic and interventional device trials, many of which are landmark trials in the field and/or leading to FDA approval in the United States. She has served as the principal investigator on numerous national and international imaging studies, device, DES and neuroprotection trials. Dr. Lansky has authored and coauthored over 500 academic peer-reviewed manuscripts in the fields of interventional cardiology, angiography, and women’s cardiovascular health. She chaired the American Heart Association Statement on Interventions in Women and most recently the Academic Research Consortium defining Neurologic Endpoints in clinical cardiovascular trials.Dr. Lansky has been recognized for her outstanding clinical research contributions with several prestigious awards including: Masters of Arts Privatim from Yale University in 2017; Thompson Reuter’s 2014 and 2016 “Most influential Scientific Minds for Clinical Medicine”; 2012 Wenger Award of Clinical Excellence in Women’s health, Visiting Professor at Fu Wai Hospital, Bejing, China and Honorary Professor, University College London.Dr. Lansky is board certified in cardiovascular diseases. A graduate of the Medical College of Virginia in Richmond, VA, she received her residency training in internal medicine, cardiology, and interventional cardiology at Washington Hospital Center, Washington DC. Dr. Lansky is a Fellow of the European Society of Cardiology,the American College of Cardiology, the American Heart Association and the Society of Cardiac Angiography and Interventions.
  • Term 2020-2023

    Professor of Surgery (Transplant); Division Chair, Transplantation Surgery and Immunology, Surgery

    David C. Mulligan, MD, is an abdominal organ transplant surgeon performing both living and deceased donor liver, kidney, and pancreas transplants. He currently serves as Professor of Surgery, Transplantation and Immunology in the Department of Surgery at Yale School of Medicine/Yale New Haven Health System. His clinical and academic focus surrounds living donor liver transplantation, expanding donation, and working on ways to utilize ex-vivo organ perfusion systems to increase transplantation in the United States. Dr. Mulligan and his team are testing novel strategies in immunosuppression; improved biomechanical organ preservation methods to reduce ischemia/reperfusion injury and promote regeneration; and working in the field of 3D bioprinting to collaborate in finding ways to grow new organs from stem cell precursors. He has performed more than 250 living donor transplants and has authored more that 180 publications. He also has served on numerous editorial review boards and presented across the U.S. and internationally. Dr. Mulligan’s leadership in solid organ transplantation across national and international platforms has grown considerably and he now serves as Past President of the United Network of Organ Sharing (UNOS)/Organ Procurement Transplant Network (OPTN), Member at-large on the Governing Board of the American Association for the Study of Liver Diseases, Past Chair of the Advisory Council on Transplantation (ACOT) to the Secretary of HHS, special government employee for FDA Medical Device Advisory Committee and chair of the Business Practice Committee of the American Society of Transplant Surgeons. He also contributes to the oversight and recommendations regarding the impacts of COVID-19 on solid organ transplantation in the U.S. for both the AASLD and the ASTS. In these visionary roles, he has led major changes in organ allocation and distribution and will hopefully culminate in substantial increases in organ transplants. Passionate about patient-centered care and building more resilient teams, he makes time to share his enjoyment of spending time in nature, especially near the ocean, with his wife and three children.
  • Term 2022-2025

    Harris Professor in the Child Study Center; Director, Yale Developmental Disabilities Clinic; Director of Undergraduate Studies, Yale Child Study Center; Co-Director of Team Science, Yale Center for Clinical Investigation (YCCI)

    James C. McPartland, Ph.D., is Professor of Child Psychiatry and Psychology at the Yale Child Study Center. He is a licensed child psychologist and Director of the Yale Developmental Disabilities Clinic. He is Director of Undergraduate Studies at the Child Study Center and teaches an undergraduate seminar on autism spectrum disorder. Dr. McPartland’s program of research investigates the brain bases of neurodevelopmental conditions to develop biologically-based tools to improve detection and treatment. His research has been continuously supported since 2007 by both federal (NIMH, NICHD, NINDS, NIDCD; R21, R03, K23, R01, U19) and private research grants (NARSAD, the Autism Science Foundation, the Waterloo Foundation, Autism Speaks, the Patterson Trust, the Simons Foundation, the Nancy Taylor Foundation, the Alan B. Slifka Foundation, the Hilibrand Foundation). He is the Principal Investigator of the Autism Biomarkers Consortium for Clinical Trials, a US-based effort to identify biomarkers to support intervention research in autism. His contributions to the field have been recognized by multiple awards, including the NARSAD Atherton Young Investigator Award, the International Society for Autism Research Young Investigator Award, the Patterson Trust Clinical Research Award, the Brain & Behavior Research Foundation Klerman Prize, and the APA Sara S. Sparrow Early Career Research Award. He is a Fellow of the American Psychological Association and the Association for Psychological Science and has published 5 books and over 170 scholarly works on autism and related topics. He has served on the executive boards of the International Society for Autism Research and the APA Division of Intellectual and Developmental Disabilities/Autism Spectrum Disorder and is on the editorial boards of the Journal of Neurodevelopmental Disorders, the Journal of Mental Health Research in Intellectual Disabilities, the Journal of Autism and Developmental Disorders, and the Encyclopedia of Autism and Related Disorders.
  • Term 2020-2023

    Professor of Psychiatry; Chief of Psychiatry, VA Connecticut Healthcare System

    Dr. Petrakis is a Professor of Psychiatry at Yale University School of Medicine and the Director of the Mental Health Service Line at VA Connecticut Healthcare System (VACHS) since July 2010. Dr. Petrakis completed residency training at Yale School of Medicine and then a NIDA-funded addiction psychiatry clinical/research fellowship. She joined the faculty in 1992. Prior to July 2010, she was the Director of the Substance Abuse Treatment Program of the VACHS since 1996. Dr. Petrakis is also the Director of the Addiction Psychiatry Residency at Yale, an ACGME-accredited program and the PI of both an NIAAA-funded and a NIDA-funded training grant (T32).Her research interests are predominately two-fold: (1) finding appropriate treatments for dually diagnosed individuals and (2) understanding the neurobiological mechanisms underlying alcohol dependence. She has received funding from the Department of Defense, NIH-NIAAA, the VA, NARSAD and the Stanley Foundation.